The health impact of SARS-CoV-2 and COVID-19 among children and adolescents with a cancer diagnosis is currently unknown. As childhood cancer is itself a rare occurrence, St. Jude Children’s Research Hospital and the International Society of Paediatric Oncology (SIOP) have created a global COVID-19 registry, so we can all learn more about the impact of the virus on our patient population and be better prepared to meet future such challenges.
We invite health care providers worldwide to voluntarily report any patient with a malignancy or prior hematopoietic stem cell transplant less than 19 years of age at the time of a laboratory-confirmed SARS-CoV-2 infection. Data reporting is requested at initial presentation of the case and at 30- and 60-days post-diagnosis follow-up.
Using the aggregate information from these reported cases, we aim to provide updates to the global pediatric cancer community and leverage the data to support community-initiated online case discussions. The success of this initiative depends on our collective voluntary participation as a global community so that the most children benefit from our evolving, shared knowledge of the pandemic.
